Skip to content
Home/Companies/Healthcare/EMAS Pharma

EMAS Pharma

Healthcare·UK·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns EMAS Pharma?

EMAS Pharma is currently owned by Kester Capital through Kester Capital III (2023 vintage), since 2024.

Hand-verified · updated 2026-07-16

Kester Capital
Investor
Kester Capital
Kester Capital III · 2023 · Small-Mid Buyout

Key facts

HQUK
SectorHealthcare
StatusActive

More from Kester Capital III

Other portfolio companies in the same fund.

Addresscloud
Active
Data & AnalyticsUK· 2025
Re-flow
Re-flow
Active
SoftwareUK· 2025
Evestia Clinical
Evestia Clinical
Active
HealthTechUK· 2024
The Boundary
The Boundary
Active
SaaSUK· 2024
GXP Engaged
Active
Business ServicesUK· 2023
Kintiga
Kintiga
Active
Business ServicesUK· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track EMAS Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on EMAS Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue